Adrenocortical tumours: Mitotic index and nuclear size as criteria of differential diagnosis and prognosis

Arkhiv Patologii

Volumn 61, Issue 3, 1999, Pages 30-34

  Polyakova, G A ^a  

^a M F VLADIMIRSKY MOSCOW REGIONAL RESEARCH CLINICAL INSTITUTE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; ADRENAL CORTEX HYPERFUNCTION; ADRENAL CORTEX TUMOR; ARTICLE; CARCINOMA; CELL NUCLEUS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; MITOSIS INDEX; PATHOLOGY; PROGNOSIS; RISK FACTOR; ULTRASTRUCTURE;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL HYPERFUNCTION; CARCINOMA; CELL NUCLEUS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MITOTIC INDEX; PROGNOSIS; RISK FACTORS;

EID: 0033126224     PISSN: 00041955     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Evans H. L., Vassilopoulon-Sellin R. // Amer. J. clin. Path. - 1996. - Vol. 105. - P. 76-86.
2. Hough A. J., Hollifield J. W., Page D. L., Hartmann W. Y. // Amer. J. clin. Path. - Ibid. - 1979. - Vol. 72. - P. 390-399.